Long-term oxygen therapy may not benefit patients with mild to moderate chronic obstructive pulmonary disease (COPD) with low levels of…
Articles by Diogo Pinto
AstraZeneca’s triple combination therapy PT010 (budesonide/glycopyrrolate/formoterol fumarate) improved lung function and reduced the rate of exacerbations in patients with…
A 10-year study has identified several factors that are independent predictors of hospital mortality in critically ill patients with severe …
High frequency chest wall oscillation (HFCWO) vests, a type of airway clearance therapy used in several lung disorders,…
Verona Pharma has started a Phase 2 clinical trial to evaluate the potential of its nebulized RPL554 as an…
Pulmatrix‘s branded generic of Spiriva HandiHaler, called PUR0200, was shown to promote similar improvements in lung function in…
A 15-year study demonstrated how nontypeable Haemophilus influenzae (NTHi), one of the most important pathogens in chronic obstructive pulmonary disease…
The long-term use of aspirin was found to reduce the severity of acute exacerbations in chronic obstructive pulmonary disease (AECOPD),…